Zhonghua Yu Fang Yi Xue Za Zhi. 2020 Oct 6;54(10):1060-1068. doi: 10.3760/cma.j.cn112150-20200711-00997.
Drug allergy(DA) is a common clinical allergic disease, and drug provocation tests(DPT) are currently recognized internationally as the "gold standard" for diagnosing drug allergy, but this diagnostic program has not been widely developed in China. The lack of diagnosis of drug allergy increases the risk of medication in clinical, and who also leads to unnecessary drug upgrades and drug abuse. Through consultations with clinical experts in multiple medical fields and combined with domestic rules and regulations to standardize the clinical diagnosis process of drug allergy, the Network of food and drug allergy interest group, Allergy Prevention and Control Committee of Chinese Preventive Medicine Association drafted this consensus for operating specifications of drug provocation tests, and preventing causes improper use of drugs leads to clinical medication risks.
药物过敏（DA）是一种常见的临床过敏性疾病，药物激发试验（DPT）目前在国际上被公认为诊断药物过敏的“金标准”，但该诊断程序在中国尚未得到广泛开展。药物过敏诊断的缺失增加了临床用药风险，还导致不必要的药物升级和药物滥用。通过与多个医学领域的临床专家进行磋商，并结合国内法规来规范药物过敏的临床诊断流程，食品药品过敏利益集团网络、中国预防医学会过敏防控委员会起草了本药物激发试验操作规范共识，以防止因药物使用不当导致临床用药风险。
